Association Between Periostin Expression and Disease Progression in Lichen Planopilaris: Insights Into Pathophysiology

骨膜蛋白表达与扁平苔藓疾病进展的关联:病理生理学见解

阅读:1

Abstract

INTRODUCTION: Lichen planopilaris (LPP) is the most prevalent form of scarring alopecia and lymphocytic infiltration that affects the infundibulum and isthmus, perifollicular melanophages, and perifollicular constrictive fibrosis OBJECTIVE: We aimed to assess the contribution of periostin tissue levels to the pathogenesis of LPP and its association with disease severity. METHODS: A total of 30 cases diagnosed with LPP between July 15 and October 15, 2022 were studied. Patient age, disease duration, disease severity, and periostin levels were recorded, and periostin immunohistochemistry was performed to obtain histoscores for the perifollicular area, dermoepidermal junction, fibroblasts, and inflammatory cells, and these were compared with the control group. RESULTS: The female sex predominated, with the majority (67%); 25 patients were classified with mild disease and five with severe LPP. Statistically significant differences were found in keratinocyte staining intensities between the mild and severe groups (P=0.023; P<0.01), with the LPP group exhibiting a higher rate of moderate staining intensity compared to the control group. In terms of perifollicular staining intensities, the rate of non-staining was higher in the control group compared to the LPP group. Statistically significant differences were also observed in fibroblast (P=0.001) and inflammatory cell (P=0.001) staining intensities between the groups. No statistically significant difference was found between the patients with mild or severe disease in the LPP group. CONCLUSION: The relationship between periostin and disease severity could not be conclusively established. The presence of periostin staining in all histopathologically-affected areas of patients with LPP suggests that periostin may serve as a promising marker in LPP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。